4.5 Article

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece

期刊

VACCINE
卷 41, 期 14, 页码 2343-2348

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2023.01.067

关键词

COVID-19; Booster; Vaccine effectiveness; Hospitalization; Absenteeism

向作者/读者索取更多资源

The study indicates that full (booster) vaccination against COVID-19 is effective in preventing severe outcomes in hospitalized patients during the Delta and Omicron waves. Fully vaccinated patients had lower risks of ICU admission, mechanical ventilation, and death, as well as shorter hospital stays. The overall vaccine effectiveness varied based on the severity and comorbidities of the patients.
Aim: We estimated vaccine effectiveness (VE) of full (booster) vaccination against severe outcomes in hospitalized COVID-19 patients during the Delta and Omicron waves.Methods: The study extended from November 15, 2021 to April 17, 2022. Full vaccination was defined as a primary vaccination plus a booster & GE; 6 months later.Results: We studied 1138 patients (mean age: 66.6 years), of whom 826 (72.6 %) had & GE; 1 comorbidity. Of the 1138 patients, 75 (6.6 %) were admitted to intensive care unit (ICU), 64 (5.6 %) received mechanical ventilation, and 172 (15.1 %) died. There were 386 (33.9 %) fully vaccinated, 172 (15.1 %) partially vacci-nated, and 580 (51 %) unvaccinated patients. Unvaccinated patients were absent from work for longer periods compared to partially or fully vaccinated patients (mean absence of 20.1 days versus 12.3 and 17.3 days, respectively; p-value = 0.03). Compared to unvaccinated patients, fully vaccinated patients were less likely to be admitted to ICU [adjusted relative risk (ARR: 0.49; 95 % CI: 0.29-0.84)], mechani-cally ventilated (ARR: 0.43; 95 % CI: 0.23-0.80), and die (ARR: 0.57; 95 % CI: 0.42-0.78), while they were hospitalized for significantly shorter periods (ARR: 0.79; 95 % CI: 0.70-0.89). The adjusted full VE was 48.8 % (95 % CI: 42.7 %-54.9 %) against ICU admission, 55.4 % (95 % CI: 52.0 %-56.2 %) against mechanical ventilation, and 22.6 % (95 % CI: 7.4 %-34.8 %) against death. For patients with & GE; 3 comorbidities, VE was 56.2 % (95 % CI: 43.9 %-67.1 %) against ICU admission, 60.2 % (95 % CI: 53.7 %-65.4 %) against mechanical ventilation, and 43.9 % (95 % CI: 19.9 %-59.7 %) against death.Conclusions: Full (booster) COVID-19 vaccination conferred protection against severe outcomes, pro-longed hospitalization, and prolonged work absenteeism.& COPY; 2023 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据